Literature DB >> 23115142

From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system?

Anne Marijn van der Graaf1, Tsjitske J Toering, Marijke M Faas, A Titia Lely.   

Abstract

Complicating up to 8% of pregnancies, preeclampsia is the most common glomerular disease worldwide and remains a leading cause of infant and maternal morbidity and mortality. Although the exact pathogenesis of this syndrome of hypertension and proteinuria is still incomplete, a consistent line of evidence has identified an imbalance of proangiogenic and anti-angiogenic proteins as a key factor in the development of preeclampsia. Furthermore, more attention has been recently addressed to the renin-angiotensin aldosterone system (RAAS), to provide understanding on the hypertension of preeclampsia. The imbalance of the RAAS and the imbalance between angiogenic and anti-angiogenic factors, which may be both common to preeclampsia and chronic kidney disease (CKD), might explain why a history of preeclampsia predisposes women to develop CKD. In this review, we briefly describe the characteristics of preeclampsia with a focus on the mechanisms of angiogenesis and the RAAS and its role in the pathogenesis of preeclampsia. Our main focus will be on the intriguing association between preeclampsia and the subsequent increased risk of developing CKD and on the potential mechanisms by which the risk of CKD is elevated in women with a history of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115142     DOI: 10.1093/ndt/gfs278

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

Review 1.  A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Donatella Spotti; Franca Giacchino; Rossella Attini; Monica Limardo; Stefania Maxia; Antioco Fois; Linda Gammaro; Tullia Todros
Journal:  J Nephrol       Date:  2017-04-22       Impact factor: 3.902

Review 2.  What a paediatric nephrologist should know about preeclampsia and why it matters.

Authors:  Giorgina Barbara Piccoli; Massimo Torreggiani; Romain Crochette; Gianfranca Cabiddu; Bianca Masturzo; Rossella Attini; Elisabetta Versino
Journal:  Pediatr Nephrol       Date:  2021-11-04       Impact factor: 3.651

3.  Prevalence of chronic kidney disease after preeclampsia.

Authors:  Veronica Agatha Lopes van Balen; Julia Jeltje Spaan; Tom Cornelis; Marc Erich August Spaanderman
Journal:  J Nephrol       Date:  2016-08-05       Impact factor: 3.902

4.  Clinical Predictors of Preeclampsia in Pregnant Women with Chronic Kidney Disease.

Authors:  Bogdan Marian Sorohan; Andreea Andronesi; Gener Ismail; Roxana Jurubita; Bogdan Obrisca; Cătălin Baston; Mihai Harza
Journal:  Medicina (Kaunas)       Date:  2020-04-27       Impact factor: 2.430

5.  Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD.

Authors:  Kate Wiles; Kate Bramham; Paul T Seed; Lesia O Kurlak; Hiten D Mistry; Catherine Nelson-Piercy; Liz Lightstone; Lucy C Chappell
Journal:  Kidney Int Rep       Date:  2019-03-26

6.  Prediction model development of late-onset preeclampsia using machine learning-based methods.

Authors:  Jong Hyun Jhee; SungHee Lee; Yejin Park; Sang Eun Lee; Young Ah Kim; Shin-Wook Kang; Ja-Young Kwon; Jung Tak Park
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

7.  Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia.

Authors:  R Ellis; M Katerelos; S W Choy; N Cook; M Lee; K Paizis; G Pell; S Walker; D A Power; P F Mount
Journal:  J Transl Med       Date:  2019-02-28       Impact factor: 5.531

Review 8.  Non-obstetric complications in preeclampsia.

Authors:  Katarzyna Pankiewicz; Ewa Szczerba; Tomasz Maciejewski; Anna Fijałkowska
Journal:  Prz Menopauzalny       Date:  2019-06-14

Review 9.  The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review.

Authors:  Krzysztof Ratajczyk; Andrzej Konieczny; Adrian Czekaj; Paweł Piotrów; Marek Fiutowski; Kornelia Krakowska; Paweł Kowal; Wojciech Witkiewicz; Karolina Marek-Bukowiec
Journal:  Int J Environ Res Public Health       Date:  2022-08-11       Impact factor: 4.614

10.  Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension and Preeclampsia: Cohort Norway Study.

Authors:  Grace M Egeland; Kari Klungsøyr; Nina Øyen; Grethe S Tell; Øyvind Næss; Rolv Skjærven
Journal:  Hypertension       Date:  2016-04-25       Impact factor: 10.190

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.